Quanta BioDesign, Ltd.Ohio - United States
Quanta BioDesign, Ltd. was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs. The company was founded in 1997 by Paul D. Davis, Ph.D. under the name BioOrganic Technologies, LLC. In the spring of 1999 the name was changed to Quanta BioDesign, Ltd., to better reflect the company’s mission.
Quanta BioDesign, dPEG, dPEG, discrete PEG
Quanta BioDesign is a leading supplier of dPEG® used in modification of therapeutic macromolecules, linkers in antibody-drug conjugates, bioconjugation, and surface modification